- No public price. Site CTA is "Request a Demo".
- Not disclosed
- Not disclosed
- —
- 2017
- US


Sift Healthcare RevProtect
by Sift Healthcare · founded 2017 · US
RevProtect predicts underpayments, denials and DRG downgrade risk for hospital revenue integrity teams.
On this page
Not rated: too little independent evidence yet.
- Regulatory & Compliance0/10
No public HIPAA/SOC2/BAA attestation
- Clinical Integration0/31.4
No EHR integrations listed
- Evidence Strength0/10
No peer-reviewed coverage
- Vendor & Market9/18
Founded 2017 (9 years)
- Sentiment & Transparency3.3/6.5
Pricing on request, no public amounts
▸ Show all 11 dimensions▾ Hide dimension detail
- HIPAA / SOC2 / BAA0/10
No public HIPAA/SOC2/BAA attestation
- EHR integrations (count)0/18
No EHR integrations listed
- Top-3 EHR coverage (Epic / Oracle / Athena)0/8
None of the top-3 EHRs covered
- Bidirectional write-back0/5
No bidirectional write-back documented
- Peer-reviewed papers0/7
No peer-reviewed coverage
- RCT / meta-analysis / systematic review0/3
No RCT, meta-analysis, or systematic review
- Funding & adoption signal3/12
Seed-stage or unfunded
- Years in market6/6
Founded 2017 (9 years)
- Pricing transparency3/7
Pricing on request, no public amounts
RevProtect predicts underpayments, denials and DRG downgrade risk for hospital revenue integrity teams.
No public price. Site CTA is "Request a Demo".
Evidence record
- Score computed November 2, 2026, method 1.2.0
- Review written November 2, 2026
MedAI Verdict, Sift Healthcare RevProtect record, https://medaiverdict.com/tools/sift-healthcare, version November 2, 2026
Bottom line
Sift Healthcare, based in Milwaukee, describes RevProtect as "payment intelligence that predicts, prevents, and resolves reimbursement risk for health systems," turning clinical and payments data into next-best actions across utilization review, CDI, coding and patient financial services. Hospitals and health systems are the customers, and the homepage names those four teams as the users. Whether the models are classical machine learning or include large language models is not stated.
Prediction before the bill
The reimbursement risk prediction page says the models cover underpayments, DRG downgrades and clinical takeback probability "as care is documented," in pre-bill, from clinical, 837 and 835 data. The denials page calls the product "a denial prevention solution for hospitals and health systems" that "predicts and prevents claim denials before submission."
Recommendations and deployment paths
For each at-risk case, the actionable recommendations page lists documentation gaps, tests or assessments needed, provider query details and supporting material for claims and appeals. The homepage adds denial intelligence and prioritization, plus validation and learning with ROI metrics.
Three deployment paths appear on the homepage: use Sift's own interface, embed in existing tools (the EHR or a third party) as worklists, or work through a partner. The homepage names no EHR vendor.
Customers and the 88 health systems
The homepage claims "Sift intelligence deployed across 88 health systems," "329 proprietary MS-DRG playbooks," "692 normalized clinical + financial data elements" and "10,000+ data points analyzed across the full claims lifecycle." The about page states the company's thesis: "Denials persist around 15% despite waves of 'AI solutions'."
Hartford Healthcare and ProHealth Care appear as case-study logos. Their documents, "Driving Denial Reduction And Revenue Recovery Improvement" and "ML-Driven Denials Intelligence," sit behind a form. Sift also publishes an annual Denials Insights Report, which is vendor research.
Outside Sift's own material, PubMed lists 0 results for "RevProtect."
Funding and location, as reported
Justin Nicols founded Sift in 2017 and is CEO, according to BizTimes and Tracxn coverage. BizTimes reported a US$20M Series B led by B Capital in about May 2024, with Allos Ventures, First Trust Capital Partners and Rock River Capital. The Series A is reported at $6.75M by BizTimes and $9M by FinSMEs (July 2022), and aggregators put total funding between $32.5M and $41.96M.
Security pages
The homepage, the reimbursement risk prediction page and the actionable recommendations page state no HIPAA, BAA, SOC 2 or HITRUST status. A privacy policy exists at /privacy-policy.
No listed price
Sift lists no price, and the call to action is "Request a Demo."
The verdict
RevProtect suits a hospital whose utilization review, CDI, coding and patient financial services teams want denial and downgrade risk flagged before billing, with recommendations and prioritization on each case. Sift's pages describe prediction and recommendations, so a team that wants codes assigned automatically has a gap to fill.
Editorial review last generated November 2, 2026. Synthesized from clinician sentiment, peer-reviewed coverage, and our editorial silo picks. Refined by hand where vendor facts change.
What it costs
All tiers are custom-quoted. The vendor does not publish per-provider list pricing.
| Tier | Monthly | Annual | Notes |
|---|---|---|---|
| Enterprise | Not stated | Not stated | No public price. Site CTA is "Request a Demo". |
Source: vendor pricing page. Last checked November 2, 2026.
Who builds it
Sift Healthcare RevProtect (Sift Healthcare) was founded in 2017 in US, putting it 9 years into market.


